ZSCAN10 and Cognitive impairment: Although the expression of ZSCAN10 decreases in the later stages of human embryonic development,13-16 residual expression in the brain and testis may be associated with phenotypic features that include cognitive impairment and, in some cases, microgenitalia and maldescended testis (Table 1).